ADC Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADCT and other ETFs, options, and stocks.About ADCT
ADC Therapeutics SA is a clinical-stage biotechnology company, which engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602.
CEOAmeet Mallik
CEOAmeet Mallik
Employees193
Employees193
HeadquartersEpalinges, Vaud
HeadquartersEpalinges, Vaud
Founded2011
Founded2011
Employees193
Employees193
ADCT Key Statistics
Market cap565.35M
Market cap565.35M
Price-Earnings ratio-4.06
Price-Earnings ratio-4.06
Dividend yield—
Dividend yield—
Average volume1.03M
Average volume1.03M
High today$4.80
High today$4.80
Low today$4.25
Low today$4.25
Open price$4.80
Open price$4.80
Volume511.90K
Volume511.90K
52 Week high$4.98
52 Week high$4.98
52 Week low$1.05
52 Week low$1.05
Stock Snapshot
With a market cap of 565.35M, ADC Therapeutics(ADCT) trades at $4.45. The stock has a price-to-earnings ratio of -4.06.
As of 2026-03-12, ADC Therapeutics(ADCT) stock has fluctuated between $4.25 and $4.80. The current price stands at $4.45, placing the stock +4.8% above today's low and -7.3% off the high.
ADC Therapeutics(ADCT) shares are trading with a volume of 511.9K, against a daily average of 1.03M.
In the last year, ADC Therapeutics(ADCT) shares hit a 52-week high of $4.98 and a 52-week low of $1.05.
In the last year, ADC Therapeutics(ADCT) shares hit a 52-week high of $4.98 and a 52-week low of $1.05.
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own ADCT. This list is generated using Robinhood data, and it’s not a recommendation.